Logo image of MNST

MONSTER BEVERAGE CORP (MNST) Stock Fundamental Analysis

NASDAQ:MNST - Nasdaq - US61174X1090 - Common Stock - Currency: USD

58.83  -0.34 (-0.57%)

After market: 58.79 -0.04 (-0.07%)

Fundamental Rating

6

MNST gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 32 industry peers in the Beverages industry. Both the health and profitability get an excellent rating, making MNST a very profitable company, without any liquidiy or solvency issues. MNST is quite expensive at the moment. It does show a decent growth rate. These ratings could make MNST a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year MNST was profitable.
In the past year MNST had a positive cash flow from operations.
MNST had positive earnings in each of the past 5 years.
Each year in the past 5 years MNST had a positive operating cash flow.
MNST Yearly Net Income VS EBIT VS OCF VS FCFMNST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

MNST has a better Return On Assets (18.35%) than 96.88% of its industry peers.
With a decent Return On Equity value of 23.16%, MNST is doing good in the industry, outperforming 78.13% of the companies in the same industry.
MNST's Return On Invested Capital of 23.04% is amongst the best of the industry. MNST outperforms 96.88% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MNST is significantly above the industry average of 11.57%.
The last Return On Invested Capital (23.04%) for MNST is above the 3 year average (19.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 18.35%
ROE 23.16%
ROIC 23.04%
ROA(3y)16.92%
ROA(5y)18.23%
ROE(3y)20.7%
ROE(5y)22.08%
ROIC(3y)19.65%
ROIC(5y)20.53%
MNST Yearly ROA, ROE, ROICMNST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

Looking at the Profit Margin, with a value of 20.27%, MNST belongs to the top of the industry, outperforming 90.63% of the companies in the same industry.
MNST's Profit Margin has declined in the last couple of years.
MNST has a better Operating Margin (28.00%) than 87.50% of its industry peers.
MNST's Operating Margin has declined in the last couple of years.
The Gross Margin of MNST (54.64%) is better than 68.75% of its industry peers.
In the last couple of years the Gross Margin of MNST has declined.
Industry RankSector Rank
OM 28%
PM (TTM) 20.27%
GM 54.64%
OM growth 3Y-5.5%
OM growth 5Y-3.99%
PM growth 3Y-6.78%
PM growth 5Y-5.25%
GM growth 3Y-1.24%
GM growth 5Y-1.56%
MNST Yearly Profit, Operating, Gross MarginsMNST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

9

2. Health

2.1 Basic Checks

MNST has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
MNST has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, MNST has less shares outstanding
Compared to 1 year ago, MNST has a worse debt to assets ratio.
MNST Yearly Shares OutstandingMNST Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
MNST Yearly Total Debt VS Total AssetsMNST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 23.79 indicates that MNST is not in any danger for bankruptcy at the moment.
MNST's Altman-Z score of 23.79 is amongst the best of the industry. MNST outperforms 100.00% of its industry peers.
The Debt to FCF ratio of MNST is 0.12, which is an excellent value as it means it would take MNST, only 0.12 years of fcf income to pay off all of its debts.
MNST has a better Debt to FCF ratio (0.12) than 87.50% of its industry peers.
MNST has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
MNST has a Debt to Equity ratio of 0.03. This is amongst the best in the industry. MNST outperforms 81.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.12
Altman-Z 23.79
ROIC/WACC2.56
WACC8.99%
MNST Yearly LT Debt VS Equity VS FCFMNST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

MNST has a Current Ratio of 3.37. This indicates that MNST is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 3.37, MNST belongs to the best of the industry, outperforming 81.25% of the companies in the same industry.
A Quick Ratio of 2.78 indicates that MNST has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.78, MNST belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.37
Quick Ratio 2.78
MNST Yearly Current Assets VS Current LiabilitesMNST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.75% over the past year.
MNST shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.72% yearly.
The Revenue has been growing slightly by 1.47% in the past year.
MNST shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.27% yearly.
EPS 1Y (TTM)3.75%
EPS 3Y-10.82%
EPS 5Y-4.72%
EPS Q2Q%11.9%
Revenue 1Y (TTM)1.47%
Revenue growth 3Y10.58%
Revenue growth 5Y12.27%
Sales Q2Q%-2.35%

3.2 Future

Based on estimates for the next years, MNST will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.04% on average per year.
MNST is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.05% yearly.
EPS Next Y17.7%
EPS Next 2Y14.53%
EPS Next 3Y13.01%
EPS Next 5Y15.04%
Revenue Next Year6.17%
Revenue Next 2Y7.07%
Revenue Next 3Y7%
Revenue Next 5Y8.05%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MNST Yearly Revenue VS EstimatesMNST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
MNST Yearly EPS VS EstimatesMNST Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

MNST is valuated quite expensively with a Price/Earnings ratio of 35.44.
MNST's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of MNST to the average of the S&P500 Index (27.30), we can say MNST is valued slightly more expensively.
With a Price/Forward Earnings ratio of 27.86, MNST can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MNST is on the same level as its industry peers.
MNST's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 21.76.
Industry RankSector Rank
PE 35.44
Fwd PE 27.86
MNST Price Earnings VS Forward Price EarningsMNST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MNST is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as MNST.
Industry RankSector Rank
P/FCF 31.93
EV/EBITDA 25.81
MNST Per share dataMNST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MNST does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of MNST may justify a higher PE ratio.
A more expensive valuation may be justified as MNST's earnings are expected to grow with 13.01% in the coming years.
PEG (NY)2
PEG (5Y)N/A
EPS Next 2Y14.53%
EPS Next 3Y13.01%

More info and screens

0

5. Dividend

5.1 Amount

MNST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONSTER BEVERAGE CORP

NASDAQ:MNST (7/11/2025, 8:00:00 PM)

After market: 58.79 -0.04 (-0.07%)

58.83

-0.34 (-0.57%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)07-31 2025-07-31/amc
Inst Owners68.16%
Inst Owner Change0%
Ins Owners0.49%
Ins Owner Change6.65%
Market Cap57.37B
Analysts75
Price Target63.52 (7.97%)
Short Float %2.33%
Short Ratio2.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.47%
Min EPS beat(2)-6.99%
Max EPS beat(2)0.06%
EPS beat(4)1
Avg EPS beat(4)-6.66%
Min EPS beat(4)-11.44%
Max EPS beat(4)0.06%
EPS beat(8)2
Avg EPS beat(8)-4.49%
EPS beat(12)3
Avg EPS beat(12)-5.41%
EPS beat(16)4
Avg EPS beat(16)-4.88%
Revenue beat(2)0
Avg Revenue beat(2)-4.61%
Min Revenue beat(2)-8.24%
Max Revenue beat(2)-0.98%
Revenue beat(4)0
Avg Revenue beat(4)-5.03%
Min Revenue beat(4)-8.24%
Max Revenue beat(4)-0.98%
Revenue beat(8)0
Avg Revenue beat(8)-3.85%
Revenue beat(12)1
Avg Revenue beat(12)-3.56%
Revenue beat(16)4
Avg Revenue beat(16)-1.96%
PT rev (1m)5.69%
PT rev (3m)10.08%
EPS NQ rev (1m)0.15%
EPS NQ rev (3m)3.92%
EPS NY rev (1m)-0.39%
EPS NY rev (3m)1.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.12%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-0.48%
Valuation
Industry RankSector Rank
PE 35.44
Fwd PE 27.86
P/S 7.7
P/FCF 31.93
P/OCF 28.35
P/B 8.8
P/tB 15.21
EV/EBITDA 25.81
EPS(TTM)1.66
EY2.82%
EPS(NY)2.11
Fwd EY3.59%
FCF(TTM)1.84
FCFY3.13%
OCF(TTM)2.08
OCFY3.53%
SpS7.64
BVpS6.68
TBVpS3.87
PEG (NY)2
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 18.35%
ROE 23.16%
ROCE 29.78%
ROIC 23.04%
ROICexc 31.64%
ROICexgc 68.61%
OM 28%
PM (TTM) 20.27%
GM 54.64%
FCFM 24.13%
ROA(3y)16.92%
ROA(5y)18.23%
ROE(3y)20.7%
ROE(5y)22.08%
ROIC(3y)19.65%
ROIC(5y)20.53%
ROICexc(3y)29.02%
ROICexc(5y)32.32%
ROICexgc(3y)64.44%
ROICexgc(5y)84.58%
ROCE(3y)25.4%
ROCE(5y)26.54%
ROICexcg growth 3Y-12.83%
ROICexcg growth 5Y-13.62%
ROICexc growth 3Y-5.49%
ROICexc growth 5Y-2.02%
OM growth 3Y-5.5%
OM growth 5Y-3.99%
PM growth 3Y-6.78%
PM growth 5Y-5.25%
GM growth 3Y-1.24%
GM growth 5Y-1.56%
F-Score7
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.12
Debt/EBITDA 0.09
Cap/Depr 267.77%
Cap/Sales 3.05%
Interest Coverage 71.04
Cash Conversion 93.27%
Profit Quality 119%
Current Ratio 3.37
Quick Ratio 2.78
Altman-Z 23.79
F-Score7
WACC8.99%
ROIC/WACC2.56
Cap/Depr(3y)319.34%
Cap/Depr(5y)225.06%
Cap/Sales(3y)3.21%
Cap/Sales(5y)2.29%
Profit Quality(3y)86.9%
Profit Quality(5y)86.95%
High Growth Momentum
Growth
EPS 1Y (TTM)3.75%
EPS 3Y-10.82%
EPS 5Y-4.72%
EPS Q2Q%11.9%
EPS Next Y17.7%
EPS Next 2Y14.53%
EPS Next 3Y13.01%
EPS Next 5Y15.04%
Revenue 1Y (TTM)1.47%
Revenue growth 3Y10.58%
Revenue growth 5Y12.27%
Sales Q2Q%-2.35%
Revenue Next Year6.17%
Revenue Next 2Y7.07%
Revenue Next 3Y7%
Revenue Next 5Y8.05%
EBIT growth 1Y3.72%
EBIT growth 3Y4.5%
EBIT growth 5Y7.79%
EBIT Next Year15.46%
EBIT Next 3Y11.01%
EBIT Next 5Y11.74%
FCF growth 1Y62.57%
FCF growth 3Y14.4%
FCF growth 5Y10.46%
OCF growth 1Y54.2%
OCF growth 3Y18.61%
OCF growth 5Y11.61%